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Abstract The objective of this study is to develop a
validated, patient-oriented questionnaire to assess urgency
and associated life impact. We interviewed six urogynecol-
ogists and urologists and five patients with overactive
bladder (OAB) symptoms about urinary urgency. Based on
this data, we composed the first draft of our Urgency
Severity and Impact Questionnaire (USIQ). A focus group
of OAB patients provided feedback on the USIQ draft. The
revised questionnaire has two parts: symptom severity
(USIQ-S) and related quality of life (USIQ-QOL). The
questionnaire was given to patients with clinically diag-
nosed OAB to establish face, content and discriminatory
validity. Cronbach’s alpha for the USIQ-S and USIQ-QOL
were 0.85 and 0.90, respectively. USIQ-QOL was moder-
ately correlated with UDI-6 (r=0.49, p<0.001), IIQ-7 (r=
0.77, p<0.001), and OAB-q (r=0.73, p<0.001). Mean
USIQ-QOL and USIQ-S scores differed by clinical diag-
nosis. The USIQ is an easily understood questionnaire with
adequate validity for use in clinical practice and research.
Keywords Urgency . OAB . Lower urinary tract .
Questionnaire . Health related quality of life
Introduction
The International Continence Society (ICS) defines urinary
urgency as “the complaint of a sudden compelling desire to
pass urine that is difficult to defer.” [1]. As currently
defined, urgency describes an abnormal sensation that is
distinguishable from the normal feeling of “urge” to void,
which occurs during a normal bladder-filling cycle.
Attempts to measure urgency are confounded by difficulties
in understanding its definition and the context of the normal
urge to void. Although urinary urgency is a key symptom
of overactive bladder (OAB), most OAB research concen-
trates on urinary incontinence and urinary frequency. This
may be partly due to the controversy surrounding the term
‘urgency’. The aim of our current study was to develop and
validate a urinary urgency questionnaire to measure the
severity and quality of life (QOL) impact from urinary
urgency, in order to advance the clinical understanding of
urinary urgency, and ultimately to guide the evaluation and
treatment of patients with OAB.
Materials and methods
Ethical approval for all aspects of this research was granted
by our Institutional Review Board. Developing the USIQ
was a multi-step process (Fig. 1).
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We composed the first draft of the USIQ questionnaire after
interviewing six urogynecologists and urologists across the
United States with expertise in the evaluation and treatment
of OAB. Experts offered their opinions and perceptions
regarding important aspects (domains) of patients’ experi-
ences of urinary urgency and associated bother.
Next, we recruited five patients with OAB and symp-
toms of urge incontinence based on clinical diagnosis, from
our referral urogynecology clinic. Consenting patients met
one-on-one with a psychologist (LH), who explored and
characterized their experience of urinary urgency, including
descriptions of its severity and effects on activities of daily
living. Patients again offered their opinions and perceptions
about their experiences of urinary urgency and associated
bother.
Important domains thus identified were used to construct
the initial version of the USIQ, which consisted of two parts
with an initial filter question, designated for self-adminis-
tration. We utilized the ICS definition for urgency for this
filter question. To ensure patients related their responses
only to urgency symptoms, we added the following
paragraph to our written instructions “The following
questions are only about your experience of urinary
urgency. Not about other urinary symptoms”
The first part, the Urgency Severity Questionnaire-
(USIQ-S), consisted of eight items which inquired about
urgency symptoms and severity; the second part, the
Urgency Impact Questionnaire-Quality of Life (USIQ-
QOL), consisted of seven questions adopted and modified
from the widely recognized and accepted Incontinence
Impact Questionnaire (IIQ-7) [2]. The IIQ was found to
capture all the domains which brought up by both the
Fig. 1 Overview of the valida-
tion of the USIQ
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patients and the experts. Each item of the bother from
urgency was measured originally using two different scales:
(1) a categorical scale similar to the existing IIQ-7 and (2) a
ten-point Likert scale with ‘0’ indicating no bother at all,
and ‘10’ indicating maximum bother.
Face validity
A psychologist (LH) then led a focus group of seven women
recruited from our urogynecology clinic. All participants had
a clinical diagnosis of OAB and reported urge incontinence
on the Medical Epidemiological and Social Aspects of
Aging questionnaire (MESA) [3]. Focus group participants
reviewed the USIQ draft and each participant individually
completed and added written comments on the specific
USIQ items. Next, the group together discussed issues
related to symptoms of urgency, the impact of urgency on
patients’ lives and feedback on the ability of the USIQ to
capture urgency symptoms. Based on the response of our
focus groups, a question about the impact of urgency on
sexual function was added to the USIQ-QOL.
Criterion validity
Criterion validity was established by measuring the strength of
the relationship between the USIQ-S and USIQ-QOL score(s)
and existing, validated measures of OAB symptom severity.
Since there is no gold standard measure of the severity of
urinary urgency, we explored the magnitude of the associations
between the USIQ scores and the validated Urogenital Distress
Inventory (UDI-6) [2], Incontinence Impact Questionnaire
(IIQ-7) [2], and Overactive Bladder symptom and health-
related quality of life questionnaire (OAB-Q) [4]. Forty-three
patients with a clinical diagnosis of OAB, ten of whom also
had urodynamically confirmed DOI, were recruited from our
outpatient clinic to take part in this phase of the study.
Consenting participants provided demographic data and
completed the IIQ7, UDI6, OAB-Q, and USIQ. Criterion
validity was established by correlating urodynamic parame-
ters and responses to the different questionnaires.
Discriminant validity
Discriminant validity was established by asking patients
without a clinical diagnosis of OAB to complete the same
measures at the time of urodynamic testing. Ten patients
with urodynamic stress incontinence (USI) who did not
have urge incontinence (they did not respond positively to
any urge item on MESA-urge subscale) provided demo-
graphic data and completed the USIQ, IIQ7, UDI6, OAB-
Q. Participants were asked to complete the USIQ question-
naire even if they did not have urgency symptoms and the
answer for the first question was ‘No’. We aimed to
establish that USIQ score(s) are higher among patients with
OAB than patients with USI.
Statistical analysis
Decision rules for item reduction were (1) low-item to total
correlations (<0.4); or (2) inadequate factor loading on any
factor (<0.4). All items on each USIQ subscale were
summed to score each USIQ scale. The mean value for
USIQ-S and USIQ-QOL items (item range 0–4) was
calculated, and multiplied by 25 to achieve a range of 0
to 100. Items which were responded as ‘unknown’ were
recorded as missing values. Higher scores indicate more
severe urgency symptoms and greater impact on quality of
life respectively. Cronbach’s alpha was used to assess the
internal consistency of the USIQ-S and USIQ-QOL. An
average Cronbach’s alpha of 0.7–0.8 is generally consid-
ered acceptable for demonstration of internal consistency
[5]. However, a very high alpha above 0.9 suggests highly-
related items, and item redundancy. Pearson’s correlation
coefficient was used to compare responses to the USIQ-S
and USIQ-QOL instruments to IIQ-7, UDI-6, OAB-Q,
scores and urodynamic parameters; first desire to void,
strong desire to void, and maximum cystometric capacity
(MCC). Discriminatory validity was ascertained by com-
paring USIQ scores between clinical groups (controls
without urgency versus patients with OAB) using a two-
sample t-test and the area under the Receiver Operating
Characteristic (ROC) curve. Exploratory factor analysis
was applied to estimate factor loading and to determine the
individual contribution of each item to the composite score.
A 0.05 significance level was used for all statistical tests.
No one-sided tests were done.
Results
Fifty three women with a mean age of 56 (29–87) years
participated in this study. Most participants were Caucasian
(87%).
Item reduction
We omitted the ten-point Likert scale questions leaving five
symptom severity items and eight QOL items due to the
high correlation between responses, on the five-point
categorical HRQOL scale and the ten-point Likert scale to
bother from urgency items, (r=0.89, p<0.001); the lower
discriminatory power of the ten-point Likert scale ques-
tions, measured by the area under the ROC curve (0.82
versus 0.77, respectively); and the simplicity of the
categorical scale. All items had good loading scores ranging
from 0.48 to 0.85 (Table 1).
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Internal consistency for the USIQ-S and USIQ-QOL as
measured by Cronbach’s alpha was excellent, 0.85 and
0.90, respectively. USIQ-S and USIQ-QOL scores moder-
ately correlated (r=0.69, p<0.001), thus supporting the
association between the two parts of the questionnaire.
After revision of the USIQ based on focus group
feedback and analysis described above, an optimized
version of the questionnaire with a reduced number of
items and scoring methods for both urgency severity and
for its impact on quality of life was obtained (Appendix A).
Criterion validity
USIQ-QOL, which measures the effect of urgency on
HRQOL, correlated moderately with existing, validated
HRQOL questionnaires; UDI-6 (r=0.49, p<0.001), IIQ-7
(r=0.77, p<0.001) and OAB-q (r=0.73, p<0.001). Sim-
ilar correlations were found between the USIQ-S and
UDI-6 (r=0.34, p<0.02), IIQ-7 (r=0.42, p<0.002), and
OAB-q (r=0.73, p<0.001). Except for a strong inverse
correlation between USSBQ-QOL and the volume at
which patients had strong desire to void (r=−0.81, p<
0.015), neither USIQ-S nor USIQ-QOL scores correlated
with other urodynamic parameters.
Discriminant validity
Mean USIQ-QOL and USIQ-S scores differed by clinical
diagnosis. OAB patients had higher mean USIQ-S and
USIQ-QOL scores than patients with USI (66±18 vs. 34±
24, p<0.001 and 48±22 vs. 19±25, p<0.005, respectively).
The area under the ROC curve, which was used to assess
“urgency” discrimination, was 0.87 and 0.82 for USIQ-S
and USIQ-QOL, respectively.
Discussion
We present a new questionnaire which has excellent
internal consistency, good construct, face and discrimina-
tory validity, and effectively captures the severity of
urgency and its impact on quality of life. The USIQ
addresses items which are important to patients with
symptoms of urgency regardless of their continence status.
As expected, we found a moderate correlation between
severity of urgency symptoms and their effect on patients’
quality of life. This is particularly important when
evaluating whether an individual will benefit from a
treatment for symptoms of urgency and for evaluating the
efficacy of such treatment.
Previous published questionnaires evaluate urgency
symptoms as part of the evaluation of OAB, including
day time frequency, nocturia, urgency, and urgency incon-
tinence. The Overactive Bladder Symptom Score (OABSS)
[6], has been validated in a cohort of Japanese patients. It
measures overall symptom severity due to day time
frequency, nocturia, urgency, and urge incontinence. Ur-
gency is evaluated in this questionnaire, by the following
question ‘‘How often do you have a sudden desire to
urinate, which is difficult to defer?’’. The OABSS total
score (0–15) is obtained by simple summation of the four
individual symptoms [6]. Validity and reliability was
demonstrated to be good as it was tested for the total score.
The severity of urgency is evaluated only by one question
which inquires about the frequency that patient has urgency
symptoms. Warning time and the severity of the urgency
symptoms are not captured by this questionnaire.
The Overactive Bladder Questionnaire (OAB-Q) [4] and
the primary OAB symptom Questionnaire (POSQ) [7] are
validated questionnaires which evaluate OAB symptoms and
Table 1 Exploratory factor analysis and correlation between specific items with total USIQ subscale score




During the last month what percentage of urinations had urgency? 0.71 0.79 0.0001
When you have urgency is it typically… 0.76 0.83 0.0001
How long can you wait once you have urgency? 0.47 0.65 0.0001
During the last month how much did urinary urgency bother you? 0.86 0.87 0.0001
In an average 24 hours how often was urinary urgency present? 0.86 0.87 0.0001
USIQ-QOL
Ability to do household chores, work? 0.72 0.71 0.0001
Ability to do physical activity such as walking, swimming or other exercise? 0.67 0.82 0.0001
Ability to have an intimate relationship or sexual intercourse? 0.52 0.62 0.0001
Entertainment activities such and going to movie or concert? 0.92 0.85 0.0001
Ability to travel by car or bus for a distance greater than 30 minutes away from home? 0.82 0.85 0.0001
Participating in social activities outside your home? 0.80 0.85 0.0001
Emotional health (nervousness, depression, etc)? 0.57 0.64 0.0001
Feeling frustrated? 0.8 0.81 0.0001
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related bother. The OAB-Q [4] has a second part which
assesses HRQOL in both continent and incontinent women.
Both questionnaires have specific items which inquire about
urge symptoms. A possible limitation of these questionnaires
is using the term ‘‘urge’’ rather “urgency” as this may
confuse patients who use the term urge for describing strong
desire to void. In our new questionnaire, we used the ICS
definition of urgency, and the results of our study suggest
that the questionnaire was comprehended by all participants.
The Indevus Urgency Severity Scale (IUSS) is a validated
questionnaire which evaluates the severity of urgency using a
single question [8]. The questionnaire was validated on large
population-based sample. Its main limitation is the use of a
non-ICS definition of urgency [1], “Degree of urgency is
meant to describe your urge to urinate”, a mixing of the
terms ‘‘urge’’ and “urgency” that may lead to confusion.
Using only one question may also limit the ability of the
questionnaire to capture other dimensions of urgency.
The Urgency Perception Score (UPS) was also found to be
a validated and reliable tool for evaluating urgency symptoms
[9]. The strength of this new tool is its ability to score
urgency sensation on a continuous scale with different grades
of severity. As was recognized by the authors, a limitation of
this questionnaire is that validation in males and females was
not done separately. The authors acknowledged that the two
sexes may have different etiologies for urgency and urgency
may be perceived in a different way. In addition, the UPS
questionnaire does not evaluate the effect of urgency
symptoms on patients’ quality of life.
Finally, a new validated urgency questionnaire was
published by Al-Buheissi et al. [10]. This questionnaire
contains ten items which evaluates urgency severity and
urge incontinence symptoms. The main limitation of this
questionnaire is that its scoring system does not differen-
tiate between symptoms of urgency and urge incontinence.
Moreover, the terms urgency and urge are used inter-
changeably [10]. The USIQ evaluates urgency symptoms
independent of urge incontinence. In order to ensure that
patients related their responses only to urgency symptoms,
we emphasized in our written instruction of the question-
naire that the questions inquire about urgency symptoms
and not about other lower urinary tract symptom.
In conclusion, the USIQ is an easily understood
questionnaire with adequate validity for use in research
and in clinical practice to describe the severity and life
impact of urinary urgency. Future testing will be needed to
evaluate the stability (test–retest reliability) and sensitivity
to change following treatment for urgency symptoms.
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Not At All Somewhat Moderately Quite
A Bit
Always
1 How much does urinary urgency affect your: Ability
to do household chores, do your work or schoolwork?
2 How much does urinary urgency affect your:
Ability to do physical activities such as walking,
swimming or other exercise?
3 How much does urinary urgency affect your: Ability
to have an intimate relationship or sexual intercourse?
4 How much does urinary urgency affect your:
Entertainmnetactivities such as going to a movie or concert?
5 How much does urinary urgency affect your:
Ability to travel by car or bus for a distance greater
than 30 minutes away from home?
6 How much does urinary urgency affect your:
Participating in social activities outside your home?
7 How much does urinary urgency affect your:
Emotional health (nervousness, depression, etc)?
8 How much does urinary urgency affect your:
Feeling frustrated?
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